FDA inspection
Institute for Human Gene Therapy: FDA inspection ending Mar 1, 2000
FDA inspection 20565 · Official Action Indicated (OAI) · Philadelphia, PA
Key facts
| Inspection ID | 20565 |
|---|---|
| Firm | Institute for Human Gene Therapy |
| FEI number | 3002992018 |
| Address | 3601 Spruce St |
| City | Philadelphia |
| State | PA |
| ZIP | 19104-4205 |
| Fiscal year | 2000 |
| Inspection end date | Mar 1, 2000 |
| Classification | Official Action Indicated (OAI) |
| Project area | Human Cellular, Tissue and Gene Therapies |
| Product type | Biologics, Drugs |
| Warning letter | UCM068575 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data